What is HSDT's earnings growth forecast for 2026-2026?
(NASDAQ: HSDT) Helius Medical Technologies's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.
Helius Medical Technologies's earnings in 2026 is -$370,367,000.
In 2026, HSDT is forecast to generate -$2,717,219,106 in earnings, with the lowest earnings forecast at -$2,610,661,494 and the highest earnings forecast at -$2,797,137,315.
What is HSDT's revenue growth forecast for 2026-2026?
(NASDAQ: HSDT) Helius Medical Technologies's forecast annual revenue growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.
Helius Medical Technologies's revenue in 2026 is $941,000.
In 2026, HSDT is forecast to generate $27,593,465 in revenue, with the lowest revenue forecast at $26,511,369 and the highest revenue forecast at $28,405,038.
What is HSDT's forecast return on assets (ROA) for 2026-2026?
(NASDAQ: HSDT) forecast ROA is -570.94%, which is lower than the forecast US Medical Devices industry average of 10.1%.
What is HSDT's Earnings Per Share (EPS) forecast for 2026-2026?
(NASDAQ: HSDT) Helius Medical Technologies's current Earnings Per Share (EPS) is -$1,259.62. In 2026, HSDT's EPS is forecast to hit -$65.79 (min: -$63.21, max: -$67.73).
What is HSDT's forecast return on equity (ROE) for 2026-2026?
(NASDAQ: HSDT) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.